Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Notice of AGM

17th May 2013 10:00

SOURCE BIOSCIENCE PLC - Notice of AGM

SOURCE BIOSCIENCE PLC - Notice of AGM

PR Newswire

London, May 16

17 May 2013 Source BioScience plc ('Source BioScience' or 'the Company') Notice of AGM and Annual Report

Source BioScience (LSE: SBS) announces that its 2013 Annual General Meetingwill be held at the Company's registered offices, 1 Orchard Place, NottinghamBusiness Park, Nottingham NG8 6PX at 10.30 am on 12 June 2013. Formal notice ofthis meeting is available on the website and has been posted to shareholderstogether with a copy of the 2012 Annual Report and Accounts, a copy of whichcan be downloaded from the Source BioScience website - www.sourcebioscience.com.

A copy of the 2012 Annual Report and Accounts has been submitted to theNational Storage Mechanism and will shortly be available for inspection.

-- ENDS --

For further information, please contact:

Source BioScience plcNick AshChief Executive OfficerTel: +44 (0)115 973 9010www.sourcebioscience.com

For investor and media enquiries:

N+1 Singer (Financial Advisor, Sponsor and Broker)Aubrey Powell/Joe StroudTel: +44 (0)203 201 3710www.nplus1singer.com College Hill (PR Agency to Source BioScience)Melanie Toyne-Sewell/Stefanie BacherTel: +44 (0)207 457 2020Mob: +44 (0)7792 693760Email: [email protected]

About Source BioScience:

Source BioScience plc (LSE: SBS) is an international diagnostic and geneticanalysis services business serving the healthcare and research markets. TheLifeSciences division provides core laboratory research support fromconceptualisation to implementation, calling upon a wide range of cutting-edgetechnology platforms including an online catalogue of biomolecular tools. TheGroup is a trusted provider of a complete range of sophisticated microarray,next generation and conventional sequencing services. GLP, GCP and CPAaccreditations make the sequencing offerings also very attractive forapplications in regulatory studies or clinical settings. Its Healthcareoperations provide screening products for cancer and other applications, inaddition to reference laboratory diagnostic testing for cancer and otherdiseases, in conjunction with predictive testing for treatment optimisation.The Group has its headquarters in Nottingham, UK. Further information aboutSource BioScience can be found at www.sourcebioscience.com.


Related Shares:

SBS.L
FTSE 100 Latest
Value8,275.66
Change0.00